Last updated on June 2011

A 22-week research study is evaluating if a new investigational insulin can provide effective and consistent blood sugar control in people with type 2 diabetes.


Brief description of study

A 22-week research study is evaluating if a new investigational insulin can provide effective and consistent blood sugar control in people with type 2 diabetes.

Detailed Study Description

You may qualify if you:

  • Are 18 years of age or older
  • Have taken insulin for at least 12 weeks
  • Have had a diagnosis of type 2 diabetes for at least 24 weeks
  • Have taken an unchanged dose of Oral Antidiabetic Drugs (OAD) for at least 12 weeks
  • Have an HbA1c level between 7.0-10.0%
  • Have a BMI of 45 kg/m2 or less

Contact us for more information:www.metabolic-institute.com/information.htm

Clinical Study Identifier: TX135325

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Rochelle Dobson

Metabolic Research Institute, Inc.
West Palm Beach, FL USA
  Connect »